Glydous Pharmaceuticals Private Limited

Glydous Pharmaceuticals Private Limited - pharma in Gorakhpur, Uttar Pradesh, India. FY 2026 financials & compliance.
CIN U24231UP2004PTC029218 Incorporated 08 November 2004 ROC Uttar Pradesh HQ Gorakhpur, Uttar Pradesh, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2025
₹23.42 Lakh
▼ 15% YoY
Net profit · FY 2025
₹3,528
Net margin 0.2%
EBITDA · FY 2025
₹4,142
EBITDA margin 0.2%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
22 yrs
Est. 2004
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Glydous Pharmaceuticals Private Limited

Data last updated:

Glydous Pharmaceuticals Private Limited is a private limited company based in Gorakhpur, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 08 November 2004 and has been in existence for over 22 years.

The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24231UP2004PTC029218. Its GSTIN is 09AACCG4090M1Z9 (Uttar Pradesh).

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vinod Chandra Sati and Aaditya Sati.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mig – 6 Repti Nagar – 3 Gorakhpur Gorakhpur, Uttar Pradesh, India – 273003.

As per the financials filed for FY 2025, the company reported a revenue of ₹23.42 Lakh, a decline of 15% compared to the previous year. For the same year it recorded a net profit of ₹3,528 (net margin 0.2%) and EBITDA of ₹4,142 (EBITDA margin 0.2%). Revenue has declined at a compounded annual rate (CAGR) of 10% over three years and 4% over five years.

Glydous Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-32-0009040). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24231UP2004PTC029218
Registration Number 029218
Incorporation Date 08 November 2004
ROC Uttar Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UP-32-0009040

Recognitions & Rankings of Glydous Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2021-22)
Udyam number
UDYAM-UP-32-0009040

Contact details

Glydous Pharmaceuticals Private Limited's registered office is in Gorakhpur, Uttar Pradesh. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Mig – 6 Repti Nagar – 3 Gorakhpur Gorakhpur, Uttar Pradesh, India – 273003
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Glydous Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Glydous Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Glydous Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Glydous Pharmaceuticals Private Limited, buy the company report.

Financials of Glydous Pharmaceuticals Private Limited

FY 2025 filings available

Glydous Pharmaceuticals Private Limited reported revenue of ₹23.42 Lakh (down 15% YoY) for FY 2025.

Revenue · FY 2025
₹23.42 Lakh ▼ 15%
Net profit · FY 2025
₹3,528 margin 0.2%
EBITDA · FY 2025
₹4,142 margin 0.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 15%
3 years · compounded
▲ 10%
5 years · compounded
▼ 4%
EBITDA CAGR growth
1 year
▲ 21%
3 years · compounded
▲ 26%
5 years · compounded
▲ 24%

Revenue has declined at a compounded annual rate (CAGR) of 4% over five years, including a 15% fall in the latest year. EBITDA rose 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹4,142
Profit Before Tax
Tax Expense
Net Profit (PAT)₹3,528
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin0.2%
Net Profit Margin0.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Glydous Pharmaceuticals Private Limited, buy the company report.

Board of directors of Glydous Pharmaceuticals Private Limited

Glydous Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Vinod Chandra SatiDirector08 Nov 200421 Years 11 MonthsCurrent
Aaditya SatiDirector18 Jul 20251 Years 3 MonthsCurrent

Auditor

Glydous Pharmaceuticals Private Limited is audited by NAVIN K AGARWAL & CO for the financial year 2020.

Auditor firmFinancial yearFirm registration number
NAVIN K AGARWAL & COFY 2020007013C

Shareholding

The shareholding of Glydous Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2020FY 2019FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Glydous Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Glydous Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Glydous Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
09AACCG4090M1Z9Uttar PradeshActive01 Jul 2017

To see the full GST registrations and return filing status of Glydous Pharmaceuticals Private Limited, buy the company report.

Recent activity

Glydous Pharmaceuticals Private Limited has 6 board changes on record since 2004: 3 appointments and 3 cessations. The latest: Aaditya Sati ceased to be Additional Director on 29 Sep 2025.

AGM
Glydous Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Aaditya Sati ceased to be Additional Director.
Appointed
Aaditya Sati was appointed as Director.
Filing
Glydous Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh I.
Ceased
Raj Kumar Yadav ceased to be Director.
Ceased
Sanjeev Gupta ceased to be Additional Director.
Appointed
Sanjeev Gupta was appointed as Director.
Appointed
Vinod Chandra Sati was appointed as Director.
Incorporation
08 Nov 2004
Glydous Pharmaceuticals Private Limited was registered on 08 Nov 2004 with Roc Uttar Pradesh I & aged 21 years 11 months as per MCA records.

Frequently asked questions

Glydous Pharmaceuticals is an active private limited company based in Gorakhpur, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 08 November 2004 (22+ years old) and is registered under CIN U24231UP2004PTC029218.

Glydous Pharmaceuticals has 2 current directors:

The latest financial statements of Glydous Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Glydous Pharmaceuticals is 09AACCG4090M1Z9, registered in Uttar Pradesh.

The CIN (Corporate Identification Number) of Glydous Pharmaceuticals is U24231UP2004PTC029218. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Glydous Pharmaceuticals was incorporated on 08 November 2004, making it 22+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.

Aaditya Sati ceased to be Additional Director on 29 Sep 2025. Aaditya Sati was appointed as Director on 18 Jul 2025. Raj Kumar Yadav ceased to be Director on 12 Jan 2015. Glydous Pharmaceuticals has 6 board changes on record in total.

Yes, Glydous Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-32-0009040).

The registered office of Glydous Pharmaceuticals is at Mig – 6 Repti Nagar – 3 Gorakhpur Gorakhpur, Uttar Pradesh, India – 273003.

Glydous Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.